MONOCYTE CULTURE AS A MODEL FOR IN VITRO TESTING OF PHARMACEUTICAL COMPOSITIONS IN VITRO



Cite item

Full Text

Abstract

Abstract

This study aimed to investigate the immunotropic effects of a pharmaceutical composition based on metabolites of a probiotic strain and plant components of various origins on human monocytes in vitro. The authors proposed using exometabolites of S. boulardii as the basis of all proposed formulations for the regeneration of human epithelial cells. The compositions included St. John's wort extract and coriander oil. The effectiveness of these pharmaceutical compositions was evaluated using monocytes isolated from adult humans. Mononuclear cells (MNCs) were isolated by gradient centrifugation. Monocytes were seeded into 24-well plates, co-cultured with the studied compositions (experiment) and without compositions (control). Monoclonal antibodies were used to identify the surface markers of the monocyte/macrophage lineage. Phenotypic analysis of monocytes was performed using a CytoFLEX flow cytometer. The M2 phenotype was characterized using CD204, CD163, and CD206 antibodies, while the M1 phenotype was assessed using CD80 and CD86 antibodies. It was experimentally proved that co-cultivation with St. John's wort extract induced cultured monocytes to acquire the M1 phenotype, while a significant increase in the expression of all surface markers for TLR4, CD80, and CD86 was observed. In contrast, coriander extract significantly suppressed the expression of M2 phenotype markers compared with unstimulated cells. The percentage of M2 monocytes of the CD204+, CD206+, and CD163+ phenotypes was increased after co-cultivation with both oil and after co-cultivation with S. boulardii metabolites for all the studied markers. Exposure to coriander oil and mixture No. 1 significantly reduced the gene expression of all M1 markers: TLR4, CD80, CD86. The lowering effect of M1 marker expression persisted after the addition of S. boulardii metabolites only for TLR4 and CD86 compared with the control. A subpopulation of monocytes of the TLR4+, CD204+, CD206+, CD163+ phenotype, coexpressing the M1 and M2 polarization markers was detected during co-cultivation with mixtures of both 2 and 3. The percentage of hybrid TLR4 +M2 monocytes was significantly higher in mixture 2 compared with mixture 3 (p<0.001 and p<0.05, respectively). Thus, the various mixtures studied cause polarization of monocytes in M1/M2, depending on the composition of the composition, which will allow it to be recommended for use in cosmetology and potentially medical practice, depending on the etiology of the disease.

About the authors

Marina Victorovna Nikolenko

Tyumen State Medical University, Tyumen, Russian Federation

Email: nikolenko-marina@mail.ru
ORCID iD: 0000-0002-1099-0656

D.Sc. (Biology), Professor of Microbiology Department, Tyumen State Medical University;

Head of the Laboratory of Microbiome, Regenerative Medicine and Cellular Technologies of Tyumen State Medical University

Russian Federation, 625023, Russian Federation, Tyumen, Odesskaya str., 54

Elena Gennadievna Kostolomova

Tyumen State Medical University, Tyumen, Russian Federation

Email: lenakost@mail.ru
ORCID iD: 0000-0002-0237-5522

Ph.D. of Biological Sciences, Associate Professor of the Microbiology Department, Tyumen State Medical University

Russian Federation, 625023, Russian Federation, Tyumen, Odesskaya str., 54

Darya Sergeevna Sivkova

Tyumen State Medical University, Tyumen, Russian Federation

Email: dasivkova@yandex.ru
ORCID iD: 0009-0006-5672-4608

Assistant of the Department of Microbiology Tyumen State Medical University;

Junior researcher of the Laboratory of Microbiome, Regenerative Medicine and Cellular Technologies of Tyumen State Medical University

Russian Federation, 625023, Russian Federation, Tyumen, Odesskaya str., 54

Anastasiya Ivanovna Borisenok

Tyumen State Medical University, Tyumen, Russian Federation

Email: Borisenok_A@mail.ru
ORCID iD: 0000-0002-7388-9141

Ph.D. of  Pharmaceutical Sciences, Associate Professor of the Department of Microbiology Tyumen State Medical University

Russian Federation, 625023, Russian Federation, Tyumen, Odesskaya str., 54

Natalia Viktorovna Baryshnikova

Tyumen State Medical University, Tyumen, Russian Federation

Email: barnv7600@mail.ru
ORCID iD: 0000-0001-6458-4920

Senior Lecturer of the Department of Microbiology Tyumen State Medical University

Russian Federation, 625023, Russian Federation, Tyumen, Odesskaya str., 54

Olga Ivanovna Malishevskaya

Tyumen State Medical University, Tyumen, Russian Federation

Email: olgaivan1988@yandex.ru
ORCID iD: 0000-0001-8709-5281

Ph.D. of  Pharmaceutical Sciences, Associate Professor of the Department of Pharmaceutical Disciplines, Tyumen State Medical University

Russian Federation, 625023, Russian Federation, Tyumen, Odesskaya str., 54

Ekaterina Mikhailovna Vaseva

Tyumen State Medical University, Tyumen, Russian Federation

Email: yuga-21@yandex.ru
ORCID iD: 0000-0002-5556-3180

Ph.D. of  Pharmaceutical Sciences, Associate Professor of the Department of Pharmaceutical Disciplines, Tyumen State Medical University

Russian Federation, 625023, Russian Federation, Tyumen, Odesskaya str., 54

Julia Prikhodko

Tyumen State Medical University, Tyumen, Russian Federation

Author for correspondence.
Email: 2690-1998@mail.ru
ORCID iD: 0000-0002-5553-4814

Assistant of the Department of Pharmaceutical Disciplines, Tyumen State Medical University

Russian Federation, 625023, Russian Federation, Tyumen, Odesskaya str., 54

References

  1. Baryshnikova N.V., Vaseva E.M., Sivkova D.S. et al. The influence of a composition based on exometabolites of Saccharomyces boulardii in relation to the pathogenic and persistent properties of fungi of the genus Candida // Russian Journal of Immunology. – 2024. – Vol. 27. – no. 3. – pp. 493-498. URL: https://rusimmun.ru/jour/article/view/16693 DOI: https://doi.org/10.46235/1028-7221-16693-TIO
  2. Kostolomova E.G., Timokhina T.Kh., Perunova N.B., et al. In vitro evaluation of immunomodulatory activity of Bifidobacterium bifidum 791 in the cell model of innate and adaptive immunity // Russian Journal of Immunology. – 2022. – Vol. 25. – no. 2. – pp. 213-218. URL: https://rusimmun.ru/jour/article/view/1133 DOI: https://doi.org/10.46235/1028-7221-1133-IVE
  3. Rath M, Müller I, Kropf P, et al. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages // Frontiers in Immunology. – 2014. Vol. 5. – pp. 1-10. URL:
  4. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2014.00532/full DOI: https://doi.org/10.3389/fimmu.2014.00532
  5. Tuzlak S, Dejean AS, Iannacone M, et al. Repositioning TH cell polarization from single cytokines to complex help // Nature Immunology. – 2021. – no. 22. – pp. 1210-1217. URL: https://www.nature.com/articles/s41590-021-01009-w DOI: https://doi.org/10.1038/s41590-021-01009-w
  6. Fernando M.R., Reyes J.L., Iannuzzi J., et al. The Pro-Inflammatory Cytokine, Interleukin-6, Enhances the Polarization of Alternatively Activated Macrophages // PloS one. – 2014. – Vol. 9. – no. 4. – pp. 1-12. URL:https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0094188 DOI: https://doi.org/10.1371/journal.pone.0094188
  7. Yang J., Zhang L., Yu C. et al. Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases // Biomarker Research. – 2014. – Vol. 2. – no. 1. – pp. 1-9. URL: https://biomarkerres.biomedcentral.com/articles/10.1186/2050-7771-2-1#citeas DOI: https://doi.org/10.1186/2050-7771-2-1

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) Nikolenko M.V., Kostolomova E.G., Sivkova D.S., Borisenok A.I., Baryshnikova N.V., Malishevskaya O.I., Vaseva E.M., Prikhodko J.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № 77 - 11525 от 04.01.2002.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies